Development Level

Tbio 2 | 10,625
Tchem 1 | 1,890

IMPC Term

abnormal behavior 1 | 226
decreased grip strength 1 | 123
decreased vertical activity 1 | 22
hypoactivity 1 | 89

Disease

Obesity 3 | 616
Alzheimer's disease 2 | 644
Arthritis 2 | 248
Asthma 2 | 349
Autistic Disorder 2 | 320
Cancer 2 | 2,346
Cocaine-Related Disorders 2 | 88
Eating disorder 2 | 24
Hypertension 2 | 287
Narcolepsy 2 | 58
Prader-Willi syndrome 2 | 45
Schizophrenia 2 | 501
diabetes mellitus 2 | 1,663
psoriasis 2 | 6,685
Acanthosis nigricans 1 | 14
Acne 1 | 20
Advanced sleep phase syndrome 1 | 10
Alcohol dependence 1 | 107
Amenorrhea 1 | 60
Anorexia nervosa 1 | 59
Anovulation 1 | 20
Anxiety Disorders 1 | 37
Anxiety disorder 1 | 22
Arthritis, Experimental 1 | 39
Atherosclerosis 1 | 275
Brain disease 1 | 83
Bulimia nervosa 1 | 15
Cerebrovascular disease 1 | 231
Colonic Neoplasms 1 | 126
Complex regional pain syndrome 1 | 12
Coronary artery disease 1 | 240
Crohn Disease 1 | 97
Dementia 1 | 129
Dermatitis 1 | 107
Diabetes Mellitus, Non-Insulin-Dependent 1 | 157
Epicondylitis 1 | 19
Epilepsy 1 | 346
Fatty Liver 1 | 48
Fatty liver disease 1 | 84
Female infertility 1 | 28
Fibromyalgia 1 | 22
Gastric ulcer 1 | 34
Gestational Diabetes 1 | 17
Heart disease 1 | 279
Hepatitis C 1 | 90
Heroin dependence 1 | 30
Huntington's disease 1 | 72
Hyperactive behavior 1 | 31
Hyperandrogenism 1 | 32
Hypercholesterolemia 1 | 27
Hyperglycemia 1 | 120
Hyperinsulinism 1 | 63
Hypertensive disease 1 | 193
Hyperthyroidism 1 | 50
Hypogonadism 1 | 70
Hypothyroidism 1 | 89
Infertility 1 | 163
Inflammation 1 | 109
Inflammatory bowel disease 1 | 142
Influenza 1 | 142
Insulin Resistance 1 | 48
Irritable bowel syndrome 1 | 59
Kidney disease 1 | 396
Klinefelter's syndrome 1 | 59
Lipid metabolism disorder 1 | 102
Lipodystrophy 1 | 32
Liver Cirrhosis, Experimental 1 | 108
Liver disease 1 | 219
Major Depressive Disorder 1 | 106
Mammary Neoplasms 1 | 410
Metabolic syndrome X 1 | 155
Mood disorder 1 | 10
Narcolepsy-Cataplexy Syndrome 1 | 9
Nerve Degeneration 1 | 73
Neurodegenerative Disorders 1 | 37
Neurodegenerative disease 1 | 383
Neuropathy 1 | 210
Non-alcoholic Fatty Liver Disease 1 | 40
Obesity, Morbid 1 | 6
Obstructive sleep apnea 1 | 28
Osteoporosis 1 | 257
Pain 1 | 70
Pain agnosia 1 | 99
Parkinson's disease 1 | 364
Polycystic Ovary Syndrome 1 | 332
Polyuria 1 | 6
Proteinuria 1 | 63
REM sleep behavior disorder 1 | 16
Restless legs syndrome 1 | 28
Rhinitis 1 | 46
Rosacea 1 | 18
Seizures 1 | 95
Spinocerebellar ataxia type 23 1 | 2
Substance Withdrawal Syndrome 1 | 52
Tachycardia 1 | 17
Urticaria 1 | 53
Weight Gain 1 | 87
Withdrawal disorder 1 | 19
chronic kidney disease 1 | 90
facioscapulohumeral dystrophy 1 | 286

Tissue

Endocrine System 3 | 18,512
Female tissues 3 | 18,647
Nervous System 3 | 18,561
Blood and immune system 2 | 17,995
Cardiovascular System 2 | 17,958
Digestive Tract 2 | 18,473
Liver and Pancreas 2 | 18,136
Male tissues 2 | 17,969
Skin and soft tissues 2 | 18,115
Urinary Tract 2 | 18,444
Respiratory system 1 | 17,484

Target Family

Non-IDG 3 | 11,971

Grant Application

5R01NS027645-12 3 | 3
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Orexin HCRT Tbio Non-IDG -3.27026 2104.5 162
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86
Leptin LEP Tbio Non-IDG -4.13745 15277.2 796